These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27406721)

  • 1. Chronic Lymphocytic Leukemia: An Update on Current Treatment Approaches.
    Rozman C; Montserrat E
    Hematology; 1997; 2(1):1-9. PubMed ID: 27406721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of B-cell chronic lymphocytic leukaemia: current status and future perspectives.
    Montserrat E; Bosch F; Rozman C
    J Intern Med Suppl; 1997; 740():63-7. PubMed ID: 9350185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukaemia treatment.
    Montserrat E; Rozman C
    Blood Rev; 1993 Sep; 7(3):164-75. PubMed ID: 8241831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current approaches to the treatment and management of chronic lymphocytic leukaemia.
    Montserrat E; Rozman C
    Drugs; 1994; 47 Suppl 6():1-9. PubMed ID: 7525184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S; De Rossi G; Luciani M; Levato D
    Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD154 expression triggered by purine analogues in vitro: Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia.
    Citores MJ; Castejon R; Villarreal M; Rosado S; Garcia-Marco JA; Vargas JA
    Exp Hematol; 2010 Mar; 38(3):165-73. PubMed ID: 20026377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.
    Hodgson K; Ferrer G; Pereira A; Moreno C; Montserrat E
    Br J Haematol; 2011 Jul; 154(1):14-22. PubMed ID: 21534942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in the management of chronic lymphocytic leukemia.
    Robak T
    Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine analogue-based chemotherapy regimens for second-line therapy in patients with chronic lymphocytic leukemia.
    Lamanna N; Weiss MA
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S44-9. PubMed ID: 16549114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
    Robak T; Kasznicki M
    Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel agents in chronic lymphocytic leukemia: efficacy and tolerability of new therapies.
    Lin TS
    Clin Lymphoma Myeloma; 2008 Aug; 8 Suppl 4():S137-43. PubMed ID: 18952544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia.
    Keating MJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):107-14. PubMed ID: 10561025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in the front-line management of chronic lymphocytic leukemia.
    Nabhan C; Shanafelt TD; Kay NE
    Leuk Res; 2008 May; 32(5):679-88. PubMed ID: 18191201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
    Strati P; Caligaris-Cappio F
    Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
    Nabhan C; Gartenhaus RB; Tallman MS
    Leuk Res; 2004 May; 28(5):429-42. PubMed ID: 15068894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the treatment of B-cell chronic lymphocytic leukemia.
    Cheson BD
    Oncology (Williston Park); 1990 Sep; 4(9):71-8, 83-4; disc. 84, 87-8, 90 pass. PubMed ID: 2145022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
    Kay NE
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.